5HALM E A, TEIRSTEIN A S. Management of Community-Acquired Pneumonia[J]. N Engl J Med 2002 ; 347 : 2 039 - 2 045.
6ASHLEY WAZANA. Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?[J]. JAMA, Jan 2000,283:373 - 380.
7ANGELL M. Is Aeadernic Medicine for Sale? [J]. N Engl J Med,2000,342(20) : 1 516-1 518.
8BERO L A, RENNIE D. Influences on the quality of published drug studies[J]. Int J Technol Asses.s Health Care 1996,12(2) :209 - 237.
9JOHANSEN H K, GOTZSCHE P C. Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis[J]. JAMA.
10PSATY B M, WEISS N S, FURBERG C D, et al. Surrogate end points, health outcomes, and the drug - approval process for the treatment of risk factors for cardiovascular disease[J]. JAMA 1999,282 :786 - 790.
